Efficacy of a Clinical Decision Support Tool to Promote Guideline-Concordant Evaluations in Patients With High-Risk Microscopic Hematuria: A Cluster Randomized Quality Improvement Project.

IF 5.9 2区 医学 Q1 UROLOGY & NEPHROLOGY
Journal of Urology Pub Date : 2025-05-01 Epub Date: 2025-01-24 DOI:10.1097/JU.0000000000004436
Richard S Matulewicz, Sarah Tsuruo, William C King, Arielle R Nagler, Zachary S Feuer, Adam Szerencsy, Danil V Makarov, Christina Wong, Isaac Dapkins, Leora I Horwitz, Saul Blecker
{"title":"Efficacy of a Clinical Decision Support Tool to Promote Guideline-Concordant Evaluations in Patients With High-Risk Microscopic Hematuria: A Cluster Randomized Quality Improvement Project.","authors":"Richard S Matulewicz, Sarah Tsuruo, William C King, Arielle R Nagler, Zachary S Feuer, Adam Szerencsy, Danil V Makarov, Christina Wong, Isaac Dapkins, Leora I Horwitz, Saul Blecker","doi":"10.1097/JU.0000000000004436","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>We aimed to determine whether implementation of a clinical decision support (CDS) tool integrated into the electronic health record of a multisite academic medical center increased the proportion of patients with AUA \"high-risk\" microscopic hematuria (MH) who receive guideline-concordant evaluations.</p><p><strong>Materials and methods: </strong>We conducted a 2-arm cluster randomized quality improvement project in which 202 ambulatory sites from a large health system were randomized to either have their physicians receive at time of test results an automated CDS alert for patients with high-risk MH with associated recommendations for imaging and cystoscopy (intervention) or usual care (control). Primary outcome was met if a patient underwent both imaging and cystoscopy within 180 days from MH result. Secondary outcomes assessed individual completion of imaging, cystoscopy, or placement of imaging orders.</p><p><strong>Results: </strong>There were 917 patients randomized to intervention (n = 476) or control (n = 441) arms between October and December 2021. The percentage of eligible patients for whom the alert correctly triggered in the intervention arm was 83%. Primary outcome was achieved in 0.6% vs 0.9% (relative risk 0.69; 95% CI 0.15, 3.10) of patients in the intervention and control arms, respectively. Patients in the intervention and control groups had similar rates of completed imaging (17.7% vs 14.7%) and cystoscopy (1.5% vs 0.9%). Those in the intervention arm had a higher likelihood of CT urogram order (5.5% vs 1.1%, <i>P</i> = .003) and a nonsignificant increase in urology evaluation (11.1% vs 7.5%, <i>P</i> = .09).</p><p><strong>Conclusions: </strong>Implementing an electronic health record-integrated CDS tool to promote evaluation of patients with high-risk MH did not lead to improvements in patient completion of a full guideline-concordant evaluation. The development of an algorithm to trigger a CDS alert was demonstrated to be feasible and effective. Further multilevel assessment of barriers to evaluation is necessary to continue to improve the approach to evaluating high-risk patients with MH.</p>","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"558-567"},"PeriodicalIF":5.9000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/JU.0000000000004436","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/24 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: We aimed to determine whether implementation of a clinical decision support (CDS) tool integrated into the electronic health record of a multisite academic medical center increased the proportion of patients with AUA "high-risk" microscopic hematuria (MH) who receive guideline-concordant evaluations.

Materials and methods: We conducted a 2-arm cluster randomized quality improvement project in which 202 ambulatory sites from a large health system were randomized to either have their physicians receive at time of test results an automated CDS alert for patients with high-risk MH with associated recommendations for imaging and cystoscopy (intervention) or usual care (control). Primary outcome was met if a patient underwent both imaging and cystoscopy within 180 days from MH result. Secondary outcomes assessed individual completion of imaging, cystoscopy, or placement of imaging orders.

Results: There were 917 patients randomized to intervention (n = 476) or control (n = 441) arms between October and December 2021. The percentage of eligible patients for whom the alert correctly triggered in the intervention arm was 83%. Primary outcome was achieved in 0.6% vs 0.9% (relative risk 0.69; 95% CI 0.15, 3.10) of patients in the intervention and control arms, respectively. Patients in the intervention and control groups had similar rates of completed imaging (17.7% vs 14.7%) and cystoscopy (1.5% vs 0.9%). Those in the intervention arm had a higher likelihood of CT urogram order (5.5% vs 1.1%, P = .003) and a nonsignificant increase in urology evaluation (11.1% vs 7.5%, P = .09).

Conclusions: Implementing an electronic health record-integrated CDS tool to promote evaluation of patients with high-risk MH did not lead to improvements in patient completion of a full guideline-concordant evaluation. The development of an algorithm to trigger a CDS alert was demonstrated to be feasible and effective. Further multilevel assessment of barriers to evaluation is necessary to continue to improve the approach to evaluating high-risk patients with MH.

一种临床决策支持工具促进高危显微血尿患者指南一致性评价的有效性:一项随机质量改进项目。
目的:我们旨在确定将临床决策支持(CDS)工具集成到多站点学术医疗中心的电子健康记录(EHR)中是否增加了美国泌尿学会(AUA)患者的比例。接受指南一致性评估的“高风险”显微镜下血尿(MH)患者。材料和方法:我们进行了一个双组随机质量改进项目,其中来自一个大型卫生系统的202个门诊点被随机分组,让他们的医生在检测结果时收到“高风险”MH患者的自动CDS警报,并建议进行成像和膀胱镜检查(干预)或常规护理(对照)。如果患者在MH结果后180天内同时进行了影像学检查和膀胱镜检查,则满足主要结局。次要结果评估个人影像学、膀胱镜检查或影像学检查顺序的完成情况。结果:在2021年10月至12月期间,917名患者随机分为干预组(n=476)或对照组(n=441)。在干预组中,警报正确触发的合格患者比例为83%。主要结局的实现率为0.6% vs. 0.9% (RR: 0.69;干预组和对照组患者的95% CI分别为0.15,3.10)。干预组和对照组的患者完成影像学检查(17.7%对14.7%)和膀胱镜检查(1.5%对0.9%)的比例相似。干预组患者的CT尿路图顺序的可能性更高(5.5%比1.1%,p=0.003),泌尿科评估的可能性无显著增加(11.1%比7.5%,p=0.09)。结论:实施ehr整合的CDS工具来促进高风险MH患者的评估并不能改善患者完成完整的指南一致性评估。开发一种触发CDS警报的算法被证明是可行和有效的。有必要进一步对评价障碍进行多层次评估,以继续改进MH高危患者的评价方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Urology
Journal of Urology 医学-泌尿学与肾脏学
CiteScore
11.50
自引率
7.60%
发文量
3746
审稿时长
2-3 weeks
期刊介绍: The Official Journal of the American Urological Association (AUA), and the most widely read and highly cited journal in the field, The Journal of Urology® brings solid coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of urology. This premier journal presents investigative studies on critical areas of research and practice, survey articles providing short condensations of the best and most important urology literature worldwide, and practice-oriented reports on significant clinical observations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信